PHOENIX, March 11, 2019 /PRNewswire/ -- With generous support from the Independence Blue Cross Foundation under the Supporting
This one-hour presentation, designed to educate attending physicians and medical residents on administration of buprenorphine in the emergency department (ED) for opioid overdose patients, will be offered several times throughout 2019. Buprenorphine is "One of three medications approved in the United States to treat opioid addiction, it works by easing withdrawal symptoms and cravings" Goodnough, A. (2018, August 18) This E.R. Treats Opioid Addiction on Demand. That's Very Rare.
Principal investigator, Jeanmarie Perrone, MD, FACMT, a professor of emergency medicine based at the Hospital of the University of Pennsylvania, along with co-faculty on this project, aim to demystify buprenorphine administration and to share the evidence for the efficacy of buprenorphine in the treatment of opioid use disorder. "This treatment, when initiated in the ED, doubles the rate of engagement in treatment at 30 days compared to patients given an outpatient referral for treatment. We believe that offering patients a treatment opportunity during their ED visit, destigmatizes medication use for recovery and demonstrates compassion and care to a highly at risk population," explains Dr. Perrone.
Learn more at: https://www.acmt.net/mtf/Buprenorphine101.html
The Medical Toxicology Foundation (MTF) is the charitable arm of the American College of Medical Toxicology (ACMT), a nonprofit professional membership association. The mission of MTF is 'Advancing research and education in the prevention and treatment of patients adversely impacted by drugs, chemicals and natural toxins.' The MTF supports medical toxicologists through funding for research, travel awards and education.
SOURCE American College of Medical Toxicology
Subscribe to our Free Newsletters!